Patent 9500076 was granted and assigned to Halliburton on November, 2016 by the United States Patent and Trademark Office.
In some aspects, an injection rate of an injection test applied to a subterranean region is controlled. The injection test includes a series of injection periods and shut-in intervals. Each of the injection periods is followed by a respective one of the shut-in intervals. The subterranean region is monitored during the injection test.